홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 파머슈티컬 > European Cardiovascular Drugs Markets
카테고리
파머슈티컬 (4931)
감염질환 (349)
골질환 치료 (38)
당뇨병 (194)
백신 (181)
비만치료/다이어트 (44)
비처방 의약품 (152)
수의학 (17)
신경질환 (174)
신약개발 (1529)
암치료 (941)
약물전달 (185)
의약품 규제환경 (127)
정신질환 (86)
제네릭 의약품 (128)
제약회사분석 (523)
처방약 (165)
시장보고서

European Cardiovascular Drugs Markets

리서치사 Frost & Sullivan
발행일 2006년 09월 상품코드 45500
페이지 정보 149 Pages
가격
US $ 6,500 ￦ 7,744,700 Web Access (Regional License)
US $ 7,000 ￦ 8,340,500 Hard Copy & Web Access (Regional License)


영문목차

Abstract

This research examines the European Cardiovascular Market in terms of the challenges faced by market participants, drivers and restraints in the industry, the competitive structure in the major markets, the revenue forecasts and growth rates and strategic recommendations.

Table of Contents

1. EXECUTIVE SUMMARY

Overview

  • 1. Overview of the European Cardiovascular Drugs Market

2. GLOSSARY OF TERMS

List of Terms

  • 1. Abbreviations

3. INTRODUCTION

Disease State Overview

  • 1. Disease Description and Risk Factors
  • 2. Types of Heart Disease
  • 3. Disease Management and Current Treatments

Research Methodology

  • 1. Research Methodology for the European Cardiovascular Drugs Market
  • 2. Assumptions and Limitations

4. INDUSTRY CHALLENGES

Challenges and Issues

  • 1. Challenges Facing the European Cardiovascular Drugs Market

5. MARKET ENGINEERING RESEARCH FOR WORLD CARDIOVASCULAR DRUGS MARKET

World Cardiovascular Drugs Market

  • 1. Introduction
  • 2. Measurement Analysis
  • 3. Revenue Forecasts
  • 4. Trends by Geographic Regions
  • 5. Segment Analysis

6. MARKET ENGINEERING RESEARCH FOR EUROPEAN CARDIOVASCULAR DRUGS MARKET

European Cardiovascular Drugs Market

  • 1. Introduction and Market Segmentation
  • 2. Measurements Analysis
  • 3. Key Market Drivers
  • 4. Key Market Restraints
  • 5. Revenue Forecasts
  • 6. Segment-wise Analysis

7. CARDIOVASCULAR DRUGS MARKET IN THE UNITED KINGDOM

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

8. CARDIOVASCULAR DRUGS MARKET IN GERMANY

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

9. CARDIOVASCULAR DRUGS MARKET IN FRANCE

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

10. CARDIOVASCULAR DRUGS MARKET IN ITALY

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

11. CARDIOVASCULAR DRUGS MARKET IN SPAIN

Research

  • 1. Market Overview
  • 2. Revenue Forecasts

12. PORTFOLIO ANALYSIS

Company Profiles and Product Pipeline

  • 1. AstraZeneca
  • 2. Bristol-Myers Squibb
  • 3. Merck & Co. Inc
  • 4. Novartis
  • 5. Pfizer
  • 6. Sanofi-Aventis

13. STRATEGIC RECOMMENDATIONS

Recommendations

  • 1. Strategic Recommendations for the European Cardiovascular Drugs Market

14. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

  • 1. Major Participants

15. DECISION SUPPORT DATABASES

Cardiovascular Diseases

  • 1. Cardiovascular Prevalence
  • 2. Percent of Cardiovascular Disease Prevalence
  • 3. Prevalence of Hypertension
  • 4. Prevalence of Hypertension as Percentage of Population
  • 5. Incidence of Myocardial Infarction
  • 6. Incidence of Stroke
  • 7. Mortality due to Coronary Heart Disease
  • 8. Mortality due to Circulatory Disease
  • 9. Mortality due to Chronic Rheumatic Heart Disease
  • 10. Heart Attack Mortality
  • 11. Mortality due to Hypertensive Diseases
Back to Top